CHNQD-00824
CHNQD-00824 is a Terphenyllin derivative with potent anticancer effect. CHNQD-00824 inhibits the proliferation and migration of cancer cells via DNA damage. CHNQD-00824 triggers apoptosis and inhibits Doxycin Hydrochloride (DOX) -induced liver-specific enlargement in zebrafish embryos. CHNQD-00824 can be used for cancer research, such as liver and breast cancer[1].
Product Specifications
CAS Number
2222643-74-3
UNSPSC
12352005
Target
Apoptosis; Caspase; Drug Derivative; PARP
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
OC1=CC=C(C2=C(C=C(C3=CC=C(C=C3)OCC=C)C(OC)=C2OCC=C)OC)C=C1
Molecular Formula
C26H26O5
Molecular Weight
418.48
References & Citations
[1]Cao XZ, et al. A Terphenyllin Derivative CHNQD-00824 from the Marine Compound Library Induced DNA Damage as a Potential Anticancer Agent. Mar Drugs. 2023 Sep 27;21 (10) :512.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC403426 20 µg
Activin A Receptor Type IC (ACVR1C) (NM_145259) Human Over-expression Lysate
Sign In for Pricing
View Details 
